Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
91.40
+6.68 (7.88%)
At close: Oct 20, 2026, 4:00 PM EDT
91.56
+0.16 (0.18%)
Pre-market: Oct 21, 2026, 4:49 AM EDT
Spyre Therapeutics Employees
Spyre Therapeutics had 125 employees as of June 30, 2026. The number of employees increased by 38 or 43.68% compared to the same quarter last year. That makes Spyre Therapeutics the 30,089th largest employer in the world and 3,841st in the United States.
Employees
125
Change
38
Growth
43.68%
Revenue / Employee
n/a
Profits / Employee
-$1,201,704
Market Cap
8.54B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 125 | 38 | 43.68% |
| Mar 31, 2026 | 112 | 39 | 53.42% |
| Dec 31, 2025 | 102 | 37 | 56.92% |
| Sep 30, 2025 | 95 | 35 | 58.33% |
| Jun 30, 2025 | 87 | 27 | 45.00% |
| Mar 31, 2025 | 73 | 43 | 143.33% |
| Dec 31, 2024 | 65 | 35 | 116.67% |
| Sep 30, 2024 | 60 | 46 | 328.57% |
| Dec 31, 2023 | 30 | -39 | -56.52% |
| Jun 30, 2023 | 14 | -78 | -84.78% |
| Mar 31, 2023 | 61 | -38 | -38.38% |
| Dec 31, 2022 | 69 | -32 | -31.68% |
| Sep 30, 2022 | 69 | -21 | -23.33% |
| Jun 30, 2022 | 92 | 1 | 1.10% |
| Mar 31, 2022 | 99 | 11 | 12.50% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Axsome Therapeutics | 1,346 |
| Twist Bioscience | 979 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| TG Therapeutics | 399 |
| Krystal Biotech | 295 |
SYRE News
- 1 day ago - Citi ups Spyre target, opens ‘upside 90-day catalyst watch’ - TheFly
- 2 days ago - Spyre Therapeutics announces clinical, preclinical data presentations at UEGW - TheFly
- 2 days ago - Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026 - GlobeNewsWire
- 9 days ago - Spyre Therapeutics initiated with a Buy at UBS - TheFly
- 14 days ago - Spyre Therapeutics falls -12.8% - TheFly
- 14 days ago - Spyre Therapeutics falls -8.4% - TheFly
- 15 days ago - Spyre Therapeutics 4.12M share Spot Secondary priced at $85.00 - TheFly
- 15 days ago - Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock - GlobeNewsWire